# Effects of regorafenib (REG) therapy on health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) in the phase III CONCUR trial.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/effects-of-regorafenib-reg-therapy-on-health-related-quality-of-life-hrqol-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jane Chang,Christopher Ngai,Dawn Odom,Christina Radder,Christian Kappeler,Rui‐Hua Xu,Shukui Qin,Tae Won Kim,Jin Li |
| Citations | 2 |
| DOI | 10.1200/jco.2015.33.15_suppl.3560 |
| Fields | Economics, Econometrics and Finance,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2253782898 |
| Type | conference-abstract |
| Year | 2015 |

## Paper authors

- [Christopher Ngai](https://scholariq.org/researchers/christopher-ngai/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Paper topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.